Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM)
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the existence of heart abnormalities in patients with
diabetes and the effect of pioglitazone in correcting these abnormalities.
Phase:
Phase 4
Details
Lead Sponsor:
The University of Texas Health Science Center at San Antonio